We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.78B
AUM Growth
-$68.3M
Cap. Flow
-$132M
Cap. Flow %
-7.44%
Top 10 Hldgs %
16.28%
Holding
390
New
41
Increased
102
Reduced
174
Closed
34

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.23M
2
ASRT
Assertio
ASRT
+$8.76M
3
ITMN
INTERMUNE INC
ITMN
+$8.58M
4
EPZM
Epizyme, Inc
EPZM
+$8.51M
5
KFRC icon
Kforce
KFRC
+$8.18M

Top Sells

Rank Stock Value
1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$40.2M
2
AKRX
Akorn Inc
AKRX
+$21.7M
3
BCOV
Brightcove, Inc.
BCOV
+$10.6M
4
REXX
Rex Energy Corporation
REXX
+$8.91M
5
MTH icon
Meritage Homes
MTH
+$8.41M

Sector Composition

Rank Sector Weight
1 Industrials 17.87%
2 Technology 15.37%
3 Healthcare 14.23%
4 Financials 11.54%
5 Consumer Discretionary 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRGO icon
226
Perrigo
PRGO
$1.4B
$1.41M 0.08%
+9,101
New +$1.44M
XONE
227
DELISTED
The ExOne Company
XONE
$1.41M 0.08%
39,248
– –
AEGR
228
DELISTED
Aegerion Pharmaceuticals
AEGR
$1.4M 0.08%
30,389
-42,543
-58% -$2.49M
WMT icon
229
Walmart Inc
WMT
$871B
$1.36M 0.08%
53,295
-4,143
-7% -$104K
CTSH icon
230
Cognizant
CTSH
$21.5B
$1.32M 0.07%
+26,049
New +$1.3M
RARE icon
231
Ultragenyx Pharmaceutical
RARE
$2.65B
$1.3M 0.07%
+26,670
New +$1.37M
ASPX
232
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$1.27M 0.07%
+41,390
New +$1.11M
CPRI icon
233
Capri Holdings
CPRI
$1.77B
$1.24M 0.07%
13,243
+157
+1% +$14.2K
TNDM icon
234
Tandem Diabetes Care
TNDM
$1.17B
$1.23M 0.07%
5,587
+1,160
+26% +$296K
BX icon
235
Blackstone
BX
$104B
$1.2M 0.07%
36,725
+428
+1% +$13.7K
WT icon
236
WisdomTree
WT
$2.97B
$1.2M 0.07%
+91,124
New +$1.39M
ACNT icon
237
Ascent Industries
ACNT
$137M
$1.2M 0.07%
83,235
-16,765
-17% -$245K
ICE icon
238
Intercontinental Exchange
ICE
$82.4B
$1.19M 0.07%
29,960
– –
NTRI
239
DELISTED
NutriSystem, Inc.
NTRI
$1.18M 0.07%
78,086
– –
FBIZ icon
240
First Business Financial Services
FBIZ
$562M
$1.15M 0.06%
48,554
-53,160
-52% -$1.12M
IBM icon
241
IBM
IBM
$202B
$1.12M 0.06%
6,069
-1,360
-18% -$239K
TLOG
242
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$1.12M 0.06%
175,000
– –
RF icon
243
Regions Financial
RF
$26.3B
$1.07M 0.06%
96,182
-75,466
-44% -$795K
C icon
244
Citigroup
C
$222B
$1.04M 0.06%
21,817
+1,542
+8% +$76.8K
TPST icon
245
Tempest Therapeutics
TPST
$14.8M
$1.03M 0.06%
+40
New +$1.13M
EVDY
246
DELISTED
Everyday Health, Inc.
EVDY
$989K 0.06%
+70,728
New +$972K
JAZZ icon
247
Jazz Pharmaceuticals
JAZZ
$15.9B
$967K 0.05%
6,970
-7,698
-52% -$1.16M
CZNC icon
248
Citizens & Northern Corp
CZNC
$436M
$966K 0.05%
48,995
-49,820
-50% -$982K
PTEN icon
249
Patterson-UTI
PTEN
$3.87B
$950K 0.05%
+29,984
New +$834K
RAD
250
DELISTED
Rite Aid Corporation
RAD
$950K 0.05%
+7,578
New +$923K
8 9
10
11 12

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q1 2014 Portfolio in Review

As of Q1 2014, Emerald Advisers held 390 positions worth $1.78B, down 3.7% from $1.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Emerald Advisers withdrew a net $132M in Q1 2014, closing 34 positions and reducing 174 holdings. Its most notable exit was Akorn Inc, an estimated $21.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Emerald Advisers opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $12.4M.

  • Emerald Advisers's largest Q1 2014 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 817,410 shares worth $12.4M.
  • Emerald Advisers added most to PacWest Bancorp in Q1 2014, an estimated $7.25M increase.
  • Emerald Advisers's biggest Q1 2014 reduction was Intercept Pharmaceuticals, Inc., cutting an estimated $40.2M.
  • Emerald Advisers fully exited Akorn Inc in Q1 2014, selling an estimated $21.7M.
  • Emerald Advisers's ten largest holdings make up 16% of its $1.78B portfolio in Q1 2014.
  • Emerald Advisers opened 41 new positions and closed 34 in Q1 2014.
  • Emerald Advisers's portfolio value fell 3.7% quarter-over-quarter to $1.78B.

Based on Emerald Advisers's 13F filing for Q1 2014, filed 30 Apr 2014.